Home - Products - Others - Other Targets - Cholecystokinin Precursor (107-115) (human) (desulfated)

Cholecystokinin Precursor (107-115) (human) (desulfated)

CAS No. 198483-37-3

Cholecystokinin Precursor (107-115) (human) (desulfated)( ——— )

Catalog No. M41027 CAS No. 198483-37-3

Cholecystokinin Precursor (107-115) (human) (desulfated)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cholecystokinin Precursor (107-115) (human) (desulfated)
  • Note
    Research use only, not for human use.
  • Brief Description
    Cholecystokinin Precursor (107-115) (human) (desulfated)
  • Description
    Cholecystokinin Precursor (107-115) (human) (desulfated)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    198483-37-3
  • Formula Weight
    1074.07
  • Molecular Formula
    C47H63N9O20
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chiniofon

    Chiniofon, a halogenated 8-hydroxyquinoline, is used as an antiamebic drug. This type of anti-amebic drug exerts an anti-amebic effect by inhibiting intestinal commensal bacteria and affects amoebic dysentery, but has no effect on extra-intestinal amoebic parasites.

  • 1-[(5-chlorothiophen...

    1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid is a chemical compound.

  • 3-OMFP Cyclohexylamm...

    3-OMFP Cyclohexylammonium salt (OMFP Cyclohexylammonium salt) is a substrate for PTEN inhibition studies and can be used to measure enzyme activity in the catalytic structural domain of CDC25B.